Post a Job

Equity Calculator

Estimate what your equity could pay if the company is sold, after the dilution you expect. Gross proceeds, before taxes and deal terms.

Your offer

Estimated gross proceeds

$2M

At a $500M exit valuation. Before taxes, exercise costs, and deal terms.

Equity grant
0.50%
After 20% dilution
×0.80
Effective ownership
0.40%
Exit valuation
×$500M
Gross proceeds
$2,000,000

At other exit valuations

Same grant and dilution. Pick a row to use it as your exit valuation.

What this leaves out

  • Vesting and unvested shares
  • Strike price and exercise cost
  • Taxes
  • Liquidation preferences
  • Deal-specific terms

The figure is your share of the sale price, not what reaches your account. Options and RSUs give the same figure here; they differ in exercise cost and tax. How we model equity

Keep going

Live roles in your range

Roles whose equity range includes 0.50%.

Browse all jobs

Worked examples from real outcomes

Real funding rounds and outcomes, with the FoundingHunt Benchmark's estimated range for a founding engineer at each stage. These companies are among the largest outcomes of recent years: they show the math, not what most startups return. Each row opens the calculator at the low end of its range.

Cursor

SpaceX bought Cursor for $60 billion in SpaceX stock in August 2026.

SpaceX paid in its own shares, not cash. Its filings say some Cursor common stock became SpaceX awards that vest only if the holder stays, and it values the awards tied to staying on at $23.4B, so not every holder owned their full share outright when the sale closed.

Sources: Series A (Cursor)Series A valuation (TechCrunch)Series B valuation (TechCrunch)Series B pre-money and Series C (TechCrunch)Series C (Cursor)Series D (Cursor)Sale to SpaceX (SEC filing)Retention awards (SpaceX Q3 2026 results)

ElevenLabs

ElevenLabs has not been sold. In September 2026 it closed a $300 million share sale for staff that values it at $22 billion.

A share sale buys only part of what people hold, and ElevenLabs has not said who could sell or how much. This is the whole stake priced at $22B, not what anyone was paid.

Sources: Pre-seed (ElevenLabs)Series A (ElevenLabs)Series A valuation (Crunchbase News)Series B (ElevenLabs)Series B valuation (Fortune)Series C (TechCrunch)Series D (ElevenLabs)Series D extension (tech.eu)$22B share sale (ElevenLabs)

Figures as of October 2026. Dilution counts only the announced funding rounds, so option-pool top-ups and shares issued to buy other companies would lower every figure. All figures are gross: before tax, exercise cost, liquidation preferences and deal terms.

Questions about the estimate

What does the equity calculator estimate?

It estimates gross proceeds at a company exit by applying your dilution assumption to the grant percentage, then multiplying the resulting effective ownership by the exit valuation.

Does company stage change the calculation?

No. Company stage provides context and helps match relevant live jobs, but it does not change the gross-proceeds formula.

Does this show what my equity is worth today?

No. The results are exit scenarios, not a current valuation or guaranteed payout. Private-company equity may never become liquid.

How does dilution affect the estimate?

Dilution reduces your effective ownership. You control the dilution assumption so you can compare how different future funding outcomes affect estimated gross proceeds.

What costs and terms are excluded?

The estimate excludes vesting and unvested shares, strike price and exercise cost, taxes, liquidation preferences and other financing terms, and transaction-specific treatment of employee equity.

What happens to employee equity in an acquisition?

Treatment varies by grant agreement and transaction. Equity may convert to cash or stock, continue vesting, accelerate, or receive different treatment, so review the actual deal and grant terms.